Cellular composition of the angiofibromas in tuberous sclerosis

Pediatric Pathology and Laboratory Medicine

Volumn 16, Issue 6, 1996, Pages 893-899

  Benjamin, Denis R ^a  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

angiofibroma; dermal dendrocyte; hamartoma; immunocytochemistry; tuberous sclerosis

Indexed keywords

BLOOD CLOTTING FACTOR 13A; COLLAGEN; PROTEIN S 100;

ADULT; ARTICLE; CELL POPULATION; CELL PROLIFERATION; CLINICAL ARTICLE; HAMARTOMA; HEMANGIOFIBROMA; HUMAN; MELANOCYTE; PRIORITY JOURNAL; SKIN FIBROBLAST; SPINDLE CELL; TUBEROUS SCLEROSIS;

EID: 0029829721     PISSN: 10771042     EISSN: None     Source Type: Journal    
DOI: 10.1080/15513819609168712     Document Type: Article

References (16)

1. Nickel WR, Reed WB. Tuberous sclerosis: Special reference to the microscopic alterations in the cutaneous hamartomas. Arch Dermatol 1962:85:209-26.
2. Sanchez N, Wick M, Perry HO. Adenoma sebaceum of Pringle: A clinicopathologic review with a discussion of related pathologic entities. J Cutan Pathol 1981;8:395-403.
3. Fartasch M, Vigneswaran N, Diepgen TL, Hornstein OP. Immunohistochemical and ultrastructural study of histiocytosis X and non-X histiocytes.J Am Acad Dermatol 1990;23:885-92.
4. Kahn HK, Marks A, Thorn H, Beumal R. Role of antibody to S-100 in diagnostic pathology. AmJ Clin Pathol 1983;79:341-7.
5. Vanstapel MJ, Gatter K, de Wolf-Peeters C, Mason DY, Desmet VD. New sites of human S-100 immunoreactivity detected with monoclonal antibodies. AmJ Clin Pathol 1986:85:160-8.
6. Tsukada T, McNutt MA, Gown AM. HHF-35, a muscle actin-specific myoclonal antibody. II. Reactivity in normal, reactive and neoplastic human tissues. AmJ Pathol 1987:127:389-402.
7. Headington JT, Cerio R. Dendritic cells and dermis. AmJ Dermatopathol 1990; 12:217-20.
8. Cerio R, SpaullJ, Oliver GF, Jones EW. A study of factor XHIa and MAC 387 immunolabeling in normal and pathological skin. AmJ Dermatopathol 1990;12:221-33.
9. Gown .AM, Vogel AM, Hoak D, et al. Monoclonal antibodies specific for melanocytic tumors distinguish subpopulations of melanocytes. AmJ Pathol 1986; 123:195-203.
10. Doherty MJ, Russo GA, Jolly MW, Stewart RK. Immunoenzyme techniques in dermatopathology. J Am Acad Dermatol 1989;2():827-37.
11. Reed RJ. Neuromesenchyme. The concept of a neurocristic effector cell for dermal mesenchyme. Am J Dermatopathol 1983:5:385-95.
12. Bender BI., Yunis EY. The pathology of tuberous sclerosis. Pathol Ann 1982:17:339-82.
13. Nemes Z, Thomazy V. Factor XHIa and the classic histiocytic markers in malignant fibrous histiocytoma. A comparative immunohistochemical study. Hum Pathol 1988; 19:822-9.
14. Reid MB, Gray C, FearJD, Bird CC. Immunohistological demonstration of factors XHIa and XIIIs in reactive and neoplastic fibroblastic and fibrohistiocytic lesions. Histopathology 1986;10:1171-8.
15. Fletcher DM. Benign fibrous histiocytoma of subcutaneous and deep soft tissue; a clinicopathologic analysis of 21 cases. AmJ Surg Pathol 1990;14:801-9.
16. Janney CG, Hurt MA, Santa Cru?. DJ. Deep juvenile xanthogranuloma. AmJ Surg 1991;15:150-9.